Post
AstriVax received €2.5 million government grant for thermostable vaccines
AstriVax has received a €2.5 million government grant from the Flanders Innovation & Entrepreneurship (VLAIO) agency that will be used …
SK Bioscience gains UK authorisation for SKYCovion Covid-19 vaccine
SK Bioscience has received marketing authorisation from the UK’s medicines and healthcare products regulatory agency (MHRA) for its Covid-19 vaccine, …
Valneva seeks Health Canada approval for chikungunya vaccine
Valneva has submitted a regulatory application to Health Canada, seeking marketing approval for its chikungunya vaccine candidate, VLA1553. The vaccine is …
Roche Canada and pCPA conclude talks for Vabysmo eye therapy
Roche Canada has successfully concluded talks with the pan-Canadian Pharmaceutical Alliance (pCPA) for Vabysmo (faricimab injection). Vabysmo is administered into the …
Sun Pharma and Philogen sign licence agreement for anti-cancer therapy
Sun Pharmaceutical Industries has reached a licence agreement with Philogen for the commercialisation of Philogen's Nidlegy (Daromun) in Australia, New …
Amplo Biotechnology receives NIH-NIAMS grant for gene therapy AMP-201
Amplo Biotechnology has received a fast track phase I/II STTR grant from the NIH-NIAMS [National Institutes of Health's National Institute …
Medsenic amends licence agreement with Phebra for arsenic trioxide
Biotechnology company BioSenic’s affiliate Medsenic has amended its licence agreement with Australia-based pharmaceutical company Phebra for the oral formulation of …
Who’s saying what? Virtual Care mentions in company filings of pharmaceutical industry decreased by 38% in Q1 2023
The global pharmaceutical industry experienced a 38% drop in company filings mentions of virtual care in Q1 2023 compared with …
Who’s saying what? Regenerative Medicine mentions in company filings of pharmaceutical industry decreased by 24% in Q1 2023
The global pharmaceutical industry experienced a 24% drop in company filings mentions of regenerative medicine in Q1 2023 compared with …
Who’s saying what? Orphan Designated Drugs mentions in company filings of pharmaceutical industry decreased by 18% in Q1 2023
The global pharmaceutical industry experienced an 18% drop in company filings mentions of orphan designated drugs in Q1 2023 compared …
Who’s saying what? Microbiome mentions in company filings of pharmaceutical industry decreased by 30% in Q1 2023
The global pharmaceutical industry experienced a 30% drop in company filings mentions of microbiome in Q1 2023 compared with the …
Who’s saying what? Future of Work mentions in company filings of pharmaceutical industry decreased by 27% in Q1 2023
The global pharmaceutical industry experienced a 27% drop in company filings mentions of future of work in Q1 2023 compared …
Who’s saying what? Blockchain mentions in company filings of pharmaceutical industry increased by 17% in Q1 2023
The global pharmaceutical industry experienced a 17% rise in company filings mentions of blockchain in Q1 2023 compared with the …
Who’s saying what? Big Data mentions in company filings of pharmaceutical industry decreased by 13% in Q1 2023
The global pharmaceutical industry experienced a 13% drop in company filings mentions of big data in Q1 2023 compared with …
FDA accepts Iovance’s BLA for melanoma therapy lifileucel
The US Food and Drug Administration (FDA) has accepted Iovance Biotherapeutics’ biologics license application (BLA) for lifileucel to treat advanced …